PATFORD HOUSE PARTNERSHIP — All Prescriptions & Medications — Page 3
Practice Code: J83050 | CALNE, SN11 0EF
Showing results 101-150 of 608
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Solifenacin | 583 | 21.6K | £816 | +22.2% ▲ |
| Mometasone furoate | 577 | 626 | £4.9K | +43.7% ▲ |
| Levetiracetam | 554 | 50.8K | £8.3K | +21.0% ▲ |
| Mirabegron | 548 | 20.2K | £18.5K | +36.4% ▲ |
| Fluticasone propionate (Inhalation) | 544 | 700 | £14.3K | +40.6% ▲ |
| Carbocisteine | 541 | 77.9K | £2.3K | +1.3% vs avg |
| Perindopril erbumine | 540 | 25.5K | £2.0K | +1.7% vs avg |
| 537 | 71.1K | £2.9K | +309.9% ▲ | |
| Insulin glargine | 530 | 3,491 | £27.5K | +86.7% ▲ |
| Bumetanide | 518 | 24.0K | £2.3K | +90.1% ▲ |
| Sumatriptan succinate | 512 | 4,698 | £4.3K | +44.6% ▲ |
| Other emollient preparations | 498 | 254.5K | £3.4K | -17.1% ▼ |
| Clarithromycin | 493 | 11.3K | £2.3K | +100.9% ▲ |
| 475 | 72.6K | £3.2K | +0.1% vs avg | |
| Senna | 472 | 22.8K | £513 | -21.6% ▼ |
| Quinine sulfate | 470 | 16.1K | £2.6K | +62.3% ▲ |
| Eplerenone | 452 | 14.9K | £1.8K | +70.4% ▲ |
| Methylprednisolone acetate | 446 | 455 | £1.4K | +286.3% ▲ |
| Ferrous sulfate | 444 | 25.0K | £979 | -13.6% ▼ |
| Loratadine | 441 | 22.7K | £500 | +111.1% ▲ |
| Umeclidinium bromide/vilanterol | 439 | 556 | £17.1K | +125.1% ▲ |
| Donepezil hydrochloride | 426 | 11.1K | £433 | +38.1% ▲ |
| Mebeverine hydrochloride | 421 | 35.4K | £1.4K | +35.6% ▲ |
| Isosorbide mononitrate | 419 | 14.1K | £2.3K | -36.6% ▼ |
| Felodipine | 413 | 17.8K | £1.6K | -30.5% ▼ |
| Loperamide hydrochloride | 407 | 43.0K | £3.5K | +74.8% ▲ |
| Linagliptin | 401 | 15.5K | £17.4K | -2.1% ▼ |
| Diltiazem hydrochloride | 396 | 23.8K | £4.4K | +28.9% ▲ |
| Trimethoprim | 395 | 12.7K | £723 | +93.3% ▲ |
| Fluticasone furoate | 375 | 412 | £2.9K | +93.6% ▲ |
| Fluticasone/umeclidinium/vilanterol | 372 | 468 | £19.7K | +58.7% ▲ |
| Escitalopram | 361 | 13.8K | £801 | +26.8% ▲ |
| Nortriptyline | 351 | 26.5K | £1.1K | +141.3% ▲ |
| Beclometasone dipropionate | 346 | 374 | £1.0K | +60.9% ▲ |
| Mesalazine (Systemic) | 336 | 31.1K | £19.0K | +40.3% ▲ |
| Glyceryl trinitrate | 336 | 1,029 | £853 | +42.1% ▲ |
| 335 | 3,374 | £1.1K | +34.3% ▲ | |
| Prochlorperazine maleate | 325 | 16.2K | £1.1K | +60.8% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 325 | 45.1K | £2.9K | +43.8% ▲ |
| Lactulose | 324 | 214.9K | £2.0K | -1.6% vs avg |
| Semaglutide | 322 | 2,253 | £26.9K | +33.7% ▲ |
| Tiotropium bromide | 317 | 2,658 | £7.6K | +4.3% ▲ |
| Tadalafil | 316 | 6,072 | £1.3K | +85.8% ▲ |
| Anastrozole | 314 | 12.3K | £468 | +244.8% ▲ |
| 314 | 322 | £1.9K | +32.9% ▲ | |
| Hyoscine butylbromide | 309 | 31.9K | £2.3K | +32.6% ▲ |
| 308 | 123.6K | £1.8K | +16.7% ▲ | |
| Carbamazepine | 304 | 36.6K | £2.6K | +2.4% ▲ |
| Olanzapine | 301 | 8,023 | £903 | -18.7% ▼ |
| Paroxetine hydrochloride | 294 | 12.0K | £879 | +57.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.